VivoSim Labs (VIVS) Inventory (2011 - 2024)

VivoSim Labs (VIVS) posted quarterly Inventory of $640000.0 for Q3 2024, up 56.86% quarter-over-quarter from $408000.0 in Q2 2024.

VivoSim Labs (VIVS) Inventory (2011 - 2024) Analysis & Trends

VivoSim Labs' Inventory history runs 11 years deep, the most recent figure standing at $640000.0 for Q3 2024.

In Q3 2024, Inventory changed N/A year-over-year to $640000.0; the TTM figure through Sep 2024 stood at $640000.0 (changed N/A YoY), while the FY2024 annual figure was $297000.0, changed N/A from the prior year.
Inventory for Q3 2024 stood at $640000.0, up from $408000.0 in the prior quarter.
The five-year high for Inventory was $640000.0 in Q3 2024, with the low at $297000.0 in Q2 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Inventory (Qtr)
1	Vertex Pharmaceuticals	139.57 Bn	131.72 Bn	2.84 Bn	1.77 Bn
2	Regeneron Pharmaceuticals	86.71 Bn	78.72 Bn	3.93 Bn	3.08 Bn
3	Argenx Se	65.44 Bn	60.25 Bn	1.37 Bn	371.00 Mn
4	Moderna	60.06 Bn	54.93 Bn	52.00 Mn	280.00 Mn
5	BeOne Medicines	42.16 Bn	37.06 Bn	1.53 Bn	732.60 Mn
6	Alnylam Pharmaceuticals	31.89 Bn	28.58 Bn	992.69 Mn	97.11 Mn
7	BioNTech SE	28.11 Bn	9.72 Bn	668.28 Mn	128.86 Mn
8	Insmed	27.59 Bn	26.43 Bn	358.27 Mn	142.38 Mn
9	Royalty Pharma	27.33 Bn	26.49 Bn	-	-
10	VivoSim Labs	1.45 Mn	1.45 Mn	-	-

Download Data